CONTROL OF IGE RESPONSES .3. IL-6 AND IFN-ALPHA ARE ISOTYPE-SPECIFIC REGULATORS OF PEAK BPO-SPECIFIC IGE ANTIBODY-FORMING CELL RESPONSES IN MICE

被引:12
作者
AUCI, D [1 ]
KLEINER, GI [1 ]
CHICE, SM [1 ]
DUKOR, P [1 ]
DURKIN, HG [1 ]
机构
[1] SANDOZ GMBH,A-1235 VIENNA,AUSTRIA
来源
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY | 1993年 / 66卷 / 03期
关键词
D O I
10.1006/clin.1993.1028
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The ability of cytokines (IL-4, IL-5, IL-6, IFN-α, IFN-γ, TNF-α, GmCSF) to regulate peak benzylpenicilloyl (BPO)-specific IgE antibody-forming cell (AFC) responses was investigated. These responses were induced in BALB/c mice by ip injection of BPO-keyhole limpet hemocyanin (BPO-KLH; 10 μg) in aluminum hydroxide gel on Days 0, 21, and 42. On Day 44, or on Days 43, 44, and 45, mice were injected sc with varying doses of cytokine or anti-cytokine antibody. On Day 46, the numbers of BPO-specific AFC (IgM, IgG1, IgE and IgA) in spleen were determined ex vivo in enzyme-linked immunosorbent spot assay. Among the cytokines tested, only IL-6 suppressed BPO-specific IgE AFC responses in an isotype-specific fashion (60-90%). However, treatment of mice with anti-IL-6 also suppressed these responses, suggesting that IL-6 can either suppress or increase peak antigen specific IgE responses, depending upon its concentration. Among the cytokines tested, only IFN-α increased BPO-specific IgE AFC responses in an isotype-specific fashion. Since treatment with anti-IFN-α suppressed these responses, it appears that IFN-α is required to maintain peak antigen-specific IgE AFC responses. IL-4 or IFN-γ nonspecifically suppressed responses of all isotypes. Treatment with anti-IL-4 also suppressed IgE responses, suggesting that this cytokine is required to maintain peak antigen specific IgE responses. Treatment with anti-IFN-γ increased IgE responses, indicating that IFN-γ suppresses peak antigen-specific IgE responses. © 1993 Academic Press, Inc.
引用
收藏
页码:219 / 224
页数:6
相关论文
共 24 条
  • [1] CYTOKINES - COORDINATORS OF IMMUNE AND INFLAMMATORY RESPONSES
    ARAI, K
    LEE, F
    MIYAJIMA, A
    MIYATAKE, S
    ARAI, N
    YOKOTA, T
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 1990, 59 : 783 - 836
  • [2] AUCI DL, 1992, J IMMUNOL, V149, P2241
  • [3] AUCI DL, IN PRESS IMMUNOPHARM
  • [4] BRENNING G, 1986, SCAND J HAEMATOL, V37, P280
  • [5] CARRUCCI JA, 1991, FASEB J, V5, P1372
  • [6] COFFMAN RL, 1986, J IMMUNOL, V136, P4538
  • [7] CONRAD DH, 1987, J IMMUNOL, V139, P2290
  • [8] ISHIZAKA K, 1988, ANNU REV IMMUNOL, V6, P513
  • [9] ISHIZAKA K, 1984, ANNU REV IMMUNOL, V2, P59
  • [10] JABARA HH, 1991, J IMMUNOL, V147, P1557